Keeping you informed with the latest company updates and investment insights from renowned stock market professionals:

Vox Markets Weekly Wrap

Quantum Data Energy CEO Pieter Krügel discusses record performance at Pyebridge, the forthcoming completion of Hindlip and Bordesley, and the Company’s partnership-led funding model. He also explains how QDE plans to address the rapidly growing power demands of AI datacentres.

QDE Revenue Jumps 121%—Are AI Datacentres the Next Big Growth Driver?

MedPal AI CEO Jason Drummond discusses the Group’s rapid rise to an £8.6 million annualised revenue run rate, record NHS prescription volumes and the strong launch of New Health. He also explains how cross-selling across the Group’s three recurring revenue streams could support its next phase of growth.

MedPal AI Hits £8.6m Revenue Run Rate…. It’s Just Getting Started

The plan is to have a maiden JORC resource in place by the end of the year

Great Western gears up for drilling at Defender tungsten project

In this week’s live smallcap show, I discussed my latest thoughts on 23 stock ideas. Unfortunately though my partner in crime Paul Scott couldn’t join, albeit service will resume as normal next week (ie 12noon Fri 7th Aug)

2 P's on a Pod: Small Cap Investing with Paul Hill & Paul Scott

Keeping you informed with the latest company updates and investment insights from renowned stock market professionals

Vox Markets Video Wrap

Vast is acquiring a significant portfolio of assets in Tajikistan via a reverse takeover

Vast secures term sheet for US$10 million funding package

Gunsynd Plc

Gunsynd plc is pleased to announce that an updated corporate presentation

Gunsynd Plc - Barb Gold Project Presentation

In this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 24 stock ideas.

2 P's on a Pod: Could More UK Takeovers Follow?

Richmond Hill Resources has published an updated corporate presentation highlighting the Martello Gold Project in Ontario, Canada, including its key exploration targets and planned development activities.

Richmond Hill Resources: Corporate Presentation

Great Western Mining has released its Q3 2026 Corporate Presentation, outlining its tungsten, copper, and precious metals strategy.

Great Western Mining: Corporate Presentation Q3 2026

Poolbeg Pharma has dosed the first patient in its POLB 001 TOPICAL clinical trial, marking the start of a key execution phase for its CRS prevention programme. With UCLH activated, further sites expected, interim data targeted for summer 2026 and partnering discussions ongoing, investors will be watching whether clinical progress can validate the programme’s claimed commercial potential.

Poolbeg’s Big Biotech Moment? First Patient Dosed Ahead of Key POLB 001 Data

Great Western Mining is just a few weeks away from commencing drilling at the Defender-Pine Crow tungsten project in Nevada

Shard updates on Great Western Mining, following latest tungsten results

88 Energy (88E) has released its July 2026 investor presentation. The presentation provides shareholders and prospective investors with the latest updates on the company's operations, key projects, and strategic direction.

88 Energy Investor Presentation

Results from four machine-cut channels show strong tungsten mineralisation at Defender-Pine Crow, where drilling will shortly commence

Great Western returns more positive tungsten assays from Defender-Pine Crow

In this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 17 stock ideas.

2 P's on a Pod: Profit Warnings, Takeovers & UK Small Caps

Shearwater Group has announced a five-year, circa £25 million contract expansion with a global telecoms customer, materially improving revenue visibility and supporting FY26 expectations. This morning’s appointment of Jonathan Entract as Independent Non-Executive Director and Audit Committee Chair adds a governance and capital allocation angle, with investors likely to focus on cash conversion, margin quality and whether the Group is now better positioned for its next phase o

£25m Contract, New Audit Chair — Is Shearwater Entering a New Phase?

Analyst Peter Hitchens has written an extensive research report on Quantum Helium, the company with extensive assets in Colorado. Hitchens joins Vox to tell us why he likes the company, to explain the reasoning behind his ambitious price target for the company, and to outline some of the broader economic context in which Quantum is operating.


Oak Securities Sets Ambitious Price Target For Quantum Helium

Pinnacle Silver & Gold has signed an agreement with well-known metals trader Auramet, under the terms of which  Auramet has agreed to provide US$5 million in finance for the development of the El Potrero gold and silver project in Mexico.

Pinnacle cuts deal for production finance for El Potrero

Focusrite’s latest results show improving margins, stronger cash generation and a significant reduction in net debt, helped by pricing discipline, working capital control and growth in direct-to-consumer sales. But investors will be watching whether modest revenue growth, tariff uncertainty and the Sequential impairment can give way to a more convincing phase of sustained earnings growth.

Focusrite FY Results - Strong Cash Flow, Lower Debt…….But Is Growth Really Back?

Vox Markets Weekly Video Wrap

Prospex Energy PLC

Prospex Energy PLC announced the publication of its Corporate Presentation, which is being delivered at its Annual General Meeting today. The company explicitly stated that no material new financial or other information has been provided in this presentation.

Prospex Energy PLC announced the publication of its Corporate Presentation

European Green Transition's founder and executive chairman Cathal Friel joins Vox to talk about the company's latest set of financial results - for the full year to December 2025 - and to lay out his vision for where EGT goes next. Last year was about building a foundation on which to conduct significant M&A, and in 2026 EGT has duly delivered on that vision. It has acquired a major wind services business operating in Ireland and the UK, and Friel is optimistic that revenues 

Is EGT now set for revenues of £50m?

Independent US payer research commissioned by Poolbeg Pharma (AIM: POLB) shows strong commercial backing for POLB 001 — a first-in-class preventative for cancer immunotherapy-induced CRS. Chris from Acumentis Global on what payers said, and what it means for the commercial opportunity ahead.

Poolbeg Pharma: What US Payers Really Said

MedPal AI has reported its strongest month since launch, with more than 42,250 prescription items dispensed in May and cumulative volumes now above 250,000. In this interview, CEO Jason Drummond discusses what is driving the growth, whether 34% pharmacy gross margins are sustainable, and how investors should judge the path from operational momentum to cash generation.

MedPal Hits Record Prescription Volumes & £5m Run-Rate

Great Western Mining has a significant land package along the Walker-Lane trend in Nevada, which is prospective for gold, copper and tungsten 

Great Western Mining completes initial prep work for tungsten drill programme

Great Western's shares have quadrupled in value since June last year, as the company has moved to focus on tungsten

Great Western Mining releases full year financials, well cashed-up for tungsten drilling

ACG Metals is just about finished with construction of the copper production line at its Turkish mine. This will add significant cashflow to a project that is already up and running and producing gold. ACG's chairman Artem Volynets says that in the 2027-2028 financial year EBITDA should hit US$200 million. Once the company refinances its bonds it will then be in a position to start paying dividends. It will also look upwards and outwards, and start to seek acquisitions in Eur

ACG Metals set for US$200m EBITDA next year

Great Western will receive a payments on execution and on the reaching of certain milestones by KGHM

Great Western Mining signs option agreement with KGHM for Eastside-Tango

MedPal AI (AIM: MPAL) launches New Health, a standalone GLP-1 sub-brand backed by £1.3 million of marketing, ahead of expected UK approval of Novo Nordisk’s oral Wegovy. CEO Jason Drummond on the strategy, the market, and the unit economics behind it.

MedPal AI Launches New Health — £1.3m Push Into GLP-1

Risk sentiment remains weak on Monday. The souring of sentiment corresponded with an increase in the oil price, Brent crude is above $111 per barrel, as tensions remain high in the Middle East. Stock futures in Europe are pointing to a mildly lower open, while index futures in the US are also in the red. 

The Week Ahead: Will UK bonds stabilize after Burnham pledged allegiance to fiscal rules?

In this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 19 stock ideas.

2 P's on a Pod: Is M&A a Key Signal in Equity Markets Right Now?

ZOO Digital has returned to positive adjusted EBITDA after a major restructuring, but revenue remains under pressure and the cash buffer is still relatively modest. In this interview, we test whether new RFP wins, Fast Track and AI-enabled localisation can convert the recovery story into sustainable growth.

ZOO Digital: Real Recovery or Just Cost Cuts? CEO Explains the Next Test

Andrew Catchpole, Chief Scientific Officer of hVIVO, joins Martin Luke of Vox Markets to discuss hVIVO’s newly signed £6 million influenza human challenge trial contract. Andrew explains how the study will evaluate a prophylactic antiviral treatment using hVIVO’s specialist influenza challenge model, highlighting the speed and efficiency advantages of human challenge trials, the growing focus on antiviral therapies, and why hVIVO continues to attract global clients.

hVIVO Secures £6m Influenza Human Challenge Trial Contract

B90 Holdings has more than doubled revenue and returned to profit, but the margin maths invites questions. CEO Ronny Breivik & Finance Director, Marcel Noordeloos join us to discuss the inflection, the AI-driven MarTech platform behind it, and the ambition to take the model beyond iGaming. A candid conversation on what the headline numbers say — and what they don’t

Revenue doubles as B90 returns to profitability and scales AI-driven platform

MedPal AI Plc (AIM: MPAL) has snapped up the Remedi pharmacy assets out of administration for less than half a million pounds — a deal that brings with it an NHS dispensing hub in Runcorn, a care home patient book that historically delivered over £10 million in annualised turnover, and a fleet of BD Rowa robotic dispensing kit.

MedPal AI on the Road to Breakeven

It's been around a year since Ignacio Mehech took over as chief executive at CleanTech Lithium, and in that period several significant milestones have been passed. First off, the company was awarded its operating licence, known as CEOL, for the Laguna Verde project. In addition, a pre-feasibility study was completed, which showed the net present value of Laguna Verde to be well over a billion dollars. Ignacio is currently visiting Europe to meet and update investors in person

CleanTech powering ahead with billion-dollar lithium project in Chile

Poolbeg Pharma CEO Jeremy Skillington discusses progress across POLB 001, including regulatory clearance, IP protection, US payer research and the path towards interim clinical data in cancer immunotherapy-induced CRS. He also updates investors on the company’s cash runway, partnering strategy and the potential commercial opportunity in oral GLP-1 therapies.

2026 Could Be a Defining Year for POLB 001 and Oral GLP-1

Oriole Resources has established a significant gold position in Cameroon across its Mbe and Bibemi projects. The company has recently established that there's at least 1.23 million ounces of inferred gold resource at Mbe, while at Bibemi it's moving towards a 10,000 ounce per year production scenario. Oriole's chief executive Martin Rosser joins Vox to talk about Oriole's first mover advantage in gold in Cameroon, and to tell us what the next steps will be.